About
Contact
Disclaimer
Privacy Policy
Sitemap
Claim Content

RONAK

Menu

Home
Tutorial Blog
Tamplate
Youtube to Mp3
Parse
Novel
- L Pelangi
- SK2H

Home » happy holidays

Showing posts with label happy holidays. Show all posts

Happy Christmas

December 24, 2017 Add Comment happy holidays

Happy Holidays to all our Readers

Best Wishes from TeamG

Subscribe to: Posts (Atom)

Populer Post

Guest post: will the COMBAT-MS study disrupt the MS market?

You may be aware that people living with MS in resource-poor environments are often not treated with disease-modifying therapies. To address...
Imaging B cells

B cells are becoming increasingly seen as an important subset of cells and they have been implicated as drivers of progressive MS. There wi...
HSCT in MS - what have we learnt?

More and more HSCT procedures (aka bone marrow transplants) are being performed for MS around the world than ever before. Currently, we lack...

Blog Archive

February 2018 (19)
January 2018 (35)
December 2017 (40)
November 2017 (35)
October 2017 (21)

Label Blog

#advancedMS
#anti-CD19
#BartsMS
#BrainHealth
#ChariotMS
#CharitySpeak
#Cladribine
#ClinicalTrial
#ClinicSpeak
#DietSpeak
#ECTRIMS2017
#GuestPost
#GuestSpeak
#MSBrainAttack
#MSParis2017
#MSPrevention
#NeuroSpeak
#NewSpeak
#OffLabel
#PoliticalSpeak
#ProfG
#ResearchSpeak
#ThinkHand
#Trial
2017
9-hole peg test
9-HPT
adjustment disorder
Aeitology
ageing
AHSCT
alemtuzmab
Alemtuzumab
alopecia
Amiloride
Animals Research
Anti-JCV antibody
anti-virals
Antibodies
ARNTL
Assisted suicide
astrocyte
astrocytes
Australia
B Cells
B memory cell
B memory cells
BAFF
Barts Health
Baveno
Beta Interferon
Big Pharma
Biogen
Biomarker
Biomarkers
biotin
Bladder
BMT
box-and-blocks
Brain Attack Trial
BTK
Canada
candida
cannabis
cardboard 9-HPT
CCSVI
CD19
CD20
cell lysis
Cenerimod
CHMP
Cladribine
CLOCK
clomipramine
coffee
cognition
COMBAT-MS
comorbidities
compliance
copaxone
CRAB
creative destruction
crowdfunding
Daclizumab
demyelination
derisk
diabetes
Diagnosis
Diet
Digesting science
dimethyl fumarate
disability
diurnal rhythm
DMT sequencing
DMTs
Dubai
EAE
EBV
ECF
Economic costs
EDSS
Education
EMA
Epidemiology
Epigenetics
Epilepsy
fingolimod
fingolimod; gilenya
flu
flu vaccine
Frankensense
fulminant liver toxicity
fungus
Genetics
Gilenya
glatiramer acetate
Guest Post
happy holidays
high-cost drugs
highlights
hot microglia
HSCT
hypertension
ibudilast
IFN-B
IL-17
Interleukin 17
internal clock
JC virus
JCV index
LDN
leflunomide
listeria
listeria monocytogenes
liver injury
lowlights
Lucerne
lymphoma
lymphopaenia
McDonald Criteria
Mendelian randomisation
Microglia
mitochondrial dysfunction
monitoring
MRI
MS Academy
MS at the limits
MS in the media
MS pathology
MS prevention
MS risk
MTA
myeloablative
natalizimab
Natalizumab
Nerve Impulse
neural stem cells
neurofilament
neurofilaments
NHS
NICE
nonmyeloablative
obesity
ocrelizumab
ocrevus
Off-Label
P2X7 receptor
paediatric MS
pandemic
participatory medicine
paternalism
PET
plasma cells
PML
PML Risk
PML Risk update
PNS
podcast
posters
postraumatic stress disorder
primary progressive
progressive MS
PROMS
prospect theory
QALY
reflections
relapse rate
remyelination
reverse causation
risk of MS
Rituximab
rose-tinted spectacles
RRMS
Rumble in the Jungle
scleroderma
SDMT
secondary progressive
Seizures
self-monitoring
shared decision making
side effect severity
side effects
skin
smoking
social media
Sony
SPMS
Survey
survey results
Sweden
Swiss MS Society
T regs
T25FW
teaching
Team Talk
Teriflunomide
The Charcot Project
timed-25-foot-walk
treatment algorithms
Treatments
TSPO
Tysabri and PML
Unrelated Blogger Comments
vegetarian diet
Vitamin D
Waliking- 4-AP
Walking
WebEDSS
zealots

Powered by Blogger.

Search This Blog

Report Abuse

Beranda

About Me

MODARO

View my complete profile

Blog Archive

▼ 2018 (54)
- ▼ February (19)
- ► January (35)

► 2017 (96)
- ► December (40)
- ► November (35)
- ► October (21)

Entri Populer

Guest post: will the COMBAT-MS study disrupt the MS market?

You may be aware that people living with MS in resource-poor environments are often not treated with disease-modifying therapies. To address...
Imaging B cells

B cells are becoming increasingly seen as an important subset of cells and they have been implicated as drivers of progressive MS. There wi...
HSCT in MS - what have we learnt?

More and more HSCT procedures (aka bone marrow transplants) are being performed for MS around the world than ever before. Currently, we lack...
Will Biogen walk-the-talk and do another natalizumab SPMS trial?

At #MSParis207 I presented a new analysis of the data of the ASCEND trial (natalizumab in SPMS) that shows natalizumab is very effective in...
LDN does not affect MS

"Low dose naltrexone (LDN) has become a popular off-label therapy for multiple sclerosis (MS). A few small, randomized studies indicate...
Reduce your price or else seems to be the message

To follow on from NDG story Multiple sclerosis - interferon beta, glatiramer acetate (review TA32) [ID809]: Appraisal consultation: 1 The ke...
Translocator protein: useful to see, useful to target?

Translocator protein (TSPO) is found on the outer mitochondrial membrane (in other words, on the outside of the powerhouse of the cell). It ...
Guest Post: Dr Rune. Høglund A potential pathological mechanism for memory B cells

A potential pathological mechanism for memory B cells Bio : RAH is a Norwegian MD, currently a PhD candidate in the MS section of the Clinic...
Temperature

Twists and turns in the MS research trails Hi, I am Mark Baker, a university lecturer, and I teach neuroscience to medical and science stude...
Posters Galore @ECTRIMS #MSParis2017

ECTRIMS/ACTRIMS 2017 in Paris How would I describe this year's ECTRIMS/ACTRIMS? With 10,000 participants and more than 2000 abstracts th...

Labels

#advancedMS
#anti-CD19
#BartsMS
#BrainHealth
#ChariotMS
#CharitySpeak
#Cladribine
#ClinicalTrial
#ClinicSpeak
#DietSpeak
#ECTRIMS2017
#GuestPost
#GuestSpeak
#MSBrainAttack
#MSParis2017
#MSPrevention
#NeuroSpeak
#NewSpeak
#OffLabel
#PoliticalSpeak
#ProfG
#ResearchSpeak
#ThinkHand
#Trial
2017
9-hole peg test
9-HPT
adjustment disorder
Aeitology
ageing
AHSCT
alemtuzmab
Alemtuzumab
alopecia
Amiloride
Animals Research
Anti-JCV antibody
anti-virals
Antibodies
ARNTL
Assisted suicide
astrocyte
astrocytes
Australia
B Cells
B memory cell
B memory cells
BAFF
Barts Health
Baveno
Beta Interferon
Big Pharma
Biogen
Biomarker
Biomarkers
biotin
Bladder
BMT
box-and-blocks
Brain Attack Trial
BTK
Canada
candida
cannabis
cardboard 9-HPT
CCSVI
CD19
CD20
cell lysis
Cenerimod
CHMP
Cladribine
CLOCK
clomipramine
coffee
cognition
COMBAT-MS
comorbidities
compliance
copaxone
CRAB
creative destruction
crowdfunding
Daclizumab
demyelination
derisk
diabetes
Diagnosis
Diet
Digesting science
dimethyl fumarate
disability
diurnal rhythm
DMT sequencing
DMTs
Dubai
EAE
EBV
ECF
Economic costs
EDSS
Education
EMA
Epidemiology
Epigenetics
Epilepsy
fingolimod
fingolimod; gilenya
flu
flu vaccine
Frankensense
fulminant liver toxicity
fungus
Genetics
Gilenya
glatiramer acetate
Guest Post
happy holidays
high-cost drugs
highlights
hot microglia
HSCT
hypertension
ibudilast
IFN-B
IL-17
Interleukin 17
internal clock
JC virus
JCV index
LDN
leflunomide
listeria
listeria monocytogenes
liver injury
lowlights
Lucerne
lymphoma
lymphopaenia
McDonald Criteria
Mendelian randomisation
Microglia
mitochondrial dysfunction
monitoring
MRI
MS Academy
MS at the limits
MS in the media
MS pathology
MS prevention
MS risk
MTA
myeloablative
natalizimab
Natalizumab
Nerve Impulse
neural stem cells
neurofilament
neurofilaments
NHS
NICE
nonmyeloablative
obesity
ocrelizumab
ocrevus
Off-Label
P2X7 receptor
paediatric MS
pandemic
participatory medicine
paternalism
PET
plasma cells
PML
PML Risk
PML Risk update
PNS
podcast
posters
postraumatic stress disorder
primary progressive
progressive MS
PROMS
prospect theory
QALY
reflections
relapse rate
remyelination
reverse causation
risk of MS
Rituximab
rose-tinted spectacles
RRMS
Rumble in the Jungle
scleroderma
SDMT
secondary progressive
Seizures
self-monitoring
shared decision making
side effect severity
side effects
skin
smoking
social media
Sony
SPMS
Survey
survey results
Sweden
Swiss MS Society
T regs
T25FW
teaching
Team Talk
Teriflunomide
The Charcot Project
timed-25-foot-walk
treatment algorithms
Treatments
TSPO
Tysabri and PML
Unrelated Blogger Comments
vegetarian diet
Vitamin D
Waliking- 4-AP
Walking
WebEDSS
zealots

Design: Mas Sugeng | Powered: Mas Pardi - Blogger